Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Hospital Pharmacy : Science and Practice|February 18, 2020
Telmisartan-induced sprue-like enteropathy: a case reportNatalia Alzueta, Amaya Echeverría, Lorea Sanz, et al.
Antibiotics (Basel, Switzerland)|February 25, 2023
Impact of COVID-19 Pandemic in Antibiotic Consumption in Navarre (Spain): An Interrupted Time Series AnalysisNatalia Alzueta, Amaya Echeverría, Patricia García, et al.
Gaceta Sanitaria|December 24, 2022
[Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?]Amaya Echeverría Gorriti, Natalia Alzueta Istúriz, Patricia García González, et al.
Anales Del Sistema Sanitario De Navarra|December 26, 2023
[Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients]Andrea Rodríguez Esquíroz, Lorea Sanz Álvarez, Marta Marín Marín, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 5, 2026
Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosisAndrea Rodríguez Esquíroz, Javier Garjón Parra, Amaya Echeverría Gorriti, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 10, 2026
Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary careAndrea Rodríguez Esquíroz, Amaya Echeverría Gorriti, Marta Marín Marín, et al.
Revista Espanola De Salud Publica|January 26, 2026
[Study protocol: evaluation of a pharmaceutical intervention for safe use of medications in patients with liver cirrhosis]Andrea RodrÍguez Esquíroz, Amaya Echeverría Gorriti, Marta Marín Marín, et al.
Revista Espanola De Salud Publica|June 29, 2022
[Study protocol: <i>A strategy for deprescribing statins and ezetimibe in primary prevention of cardiovascular disease in patients older than 75 years: health outcomes analysis.</i>]Natalia Alzueta Istúriz, Julen Fernández González, Amaya Echeverría Gorriti, et al.
Revista Espanola De Salud Publica|February 27, 2025
[Health outcomes of deprescribing proton pump inhibitors: study protocol]Amaya Echeverría Gorriti, Andrea Rodríguez Esquiroz, Patricia García González, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2023
Effect of the combination of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case-control studyDulce Maria Calvo, Luis Carlos Saiz, Leire Leache, et al.
Pageof 2